Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tailored diet after pancreatic surgery may speed healing

NCT ID NCT07560540

Knowledge-focused Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether personalized nutrition plans can improve recovery after Whipple surgery for pancreatic, bile duct, or ampullary cancers. Twenty patients in Pakistan will receive tailored meals and supplements before and after surgery, and be followed for 6 months. Researchers will measure body composition, blood tests, and complications to see if the approach helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized nutrition therapy (enteral and parenteral)
What this could lead to
If successful, this could provide evidence-based nutrition guidelines to help Whipple surgery patients recover faster with fewer complications.
What could go wrong
This is a very small, early-stage study (20 patients) with no control group, so results may not be generalizable. It only observes outcomes, not tests a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Malignancy of; * Distal common bile duct * Pancreatic head * Periampullary * Duodenal * Patients scheduled for elective Whipple's procedure (laparoscopic and open) * Age 18 and above Exclusion Criteria: * Patients undergoing Whipple's procedure for reasons other than malignancy * Patients undergoing emergency procedures * Patients with significant preoperative complications prohibiting oral intake * Age below 18

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ampulla of vater adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ampulla of vater adenocarcinoma bile duct cancer biliary tract cancer carcinoma of duodenum distal biliary tract carcinoma exocrine pancreatic carcinoma malignant pancreatic neoplasm pancreatic neoplasm periampullary adenocarcinoma tumor of duodenum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ampulla of vater adenocarcinoma Billiary track cancer Pancreatic cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shalamar Hospital

    RECRUITING

    Lahore, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.